(Q43280950)

English

Risk of adverse clinical outcomes with concomitant use of clopidogrel and proton pump inhibitors following percutaneous coronary intervention

scientific article published in July 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Risk of adverse clinical outcomes with concomitant use of clopidogrel and proton pump inhibitors following percutaneous coronary intervention (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

1 reference

based on heuristic

inferred from title

author name string

Ekta Gupta

1

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Darpan Bansal

2

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

John Sotos

3

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Kevin Olden

4

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

publication date

1 July 2010

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Digestive Diseases and Sciences

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

55

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

1964-1968

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

https://scigraph.springernature.com/pub.10.1007/s10620-009-0960-8

0 references

The effect of CYP2C19 polymorphism on the pharmacokinetics and pharmacodynamics of clopidogrel: a possible mechanism for clopidogrel resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/19731021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/19731021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A population-based study of the drug interaction between proton pump inhibitors and clopidogrel

1 reference

https://pubmed.ncbi.nlm.nih.gov/19731021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification and biological activity of the active metabolite of clopidogrel

1 reference

https://pubmed.ncbi.nlm.nih.gov/19731021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel

1 reference

https://pubmed.ncbi.nlm.nih.gov/19731021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Omeprazole: a possible new candidate influencing the antiplatelet effect of clopidogrel

1 reference

https://pubmed.ncbi.nlm.nih.gov/19731021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19731021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytochrome p-450 polymorphisms and response to clopidogrel

1 reference

https://pubmed.ncbi.nlm.nih.gov/19731021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19731021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Importance of hepatic metabolism in the antiaggregating activity of the thienopyridine clopidogrel

1 reference

https://pubmed.ncbi.nlm.nih.gov/19731021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities

1 reference

https://pubmed.ncbi.nlm.nih.gov/19731021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic determinants of response to clopidogrel and cardiovascular events

1 reference

https://pubmed.ncbi.nlm.nih.gov/19731021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10620-009-0960-8

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

release_ywthabxjmrh7tfueqwzukg6yry

1 reference

https://api.fatcat.wiki/v0/release/ywthabxjmrh7tfueqwzukg6yry

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43280950&oldid=1985537344"